ARCL Organics Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: April 2, 2025, 8:43 pm

Market Cap	176 Cr.
Current Price	220
High / Low	325/48.7
Stock P/E	15.8
Book Value	86.1
Dividend Yield	0.00 %
ROCE	21.5 %
ROE	18.2 %
Face Value	10.0
PEG Ratio	1.80

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for ARCL Organics Ltd

Competitors of ARCL Organics Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
ARCL Organics Ltd	176 Cr.	220	325/48.7	15.8	86.1	0.00 %	21.5 %	18.2 %	10.0
Industry Average	176.00 Cr	220.00		15.80	86.10	0.00%	21.50%	18.20%	10.00

All Competitor Stocks of ARCL Organics Ltd

Quarterly Result

Metric	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	41.00	31.71	46.44	41.58	43.25	48.33	57.57	59.93	56.46	61.96
Expenses	36.27	30.36	40.04	38.47	39.51	41.00	52.20	54.12	51.33	58.14
Operating Profit	4.73	1.35	6.40	3.11	3.74	7.33	5.37	5.81	5.13	3.82
OPM %	11.54%	4.26%	13.78%	7.48%	8.65%	15.17%	9.33%	9.69%	9.09%	6.17%
Other Income	0.58	0.01	2.25	0.43	0.64	0.81	0.82	0.41	0.71	0.83
Interest	0.44	0.45	0.51	0.51	1.03	1.85	0.76	1.25	1.23	1.14
Depreciation	1.00	0.64	1.30	1.33	1.29	1.17	0.50	1.37	1.13	1.29
Profit before tax	3.87	0.27	6.84	1.70	2.06	5.12	4.93	3.60	3.48	2.22
Tax %	28.94%	29.63%	73.39%	16.47%	55.83%	30.86%	2.03%	27.22%	42.53%	24.77%
Net Profit	2.76	0.19	1.81	1.42	0.91	3.53	4.83	2.62	2.01	1.67
EPS in Rs	3.45	0.24	2.26	1.78	1.14	4.41	6.04	3.28	2.51	2.09

Last Updated: February 28, 2025, 3:28 pm

Below is a detailed analysis of the quarterly data for ARCL Organics Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is ₹61.96 Cr.. The value appears strong and on an upward trend. It has increased from 56.46 Cr. (Sep 2024) to ₹61.96 Cr., marking an increase of 5.50 Cr..
For Expenses, as of Dec 2024, the value is ₹58.14 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 51.33 Cr. (Sep 2024) to ₹58.14 Cr., marking an increase of 6.81 Cr..
For Operating Profit, as of Dec 2024, the value is ₹3.82 Cr.. The value appears to be declining and may need further review. It has decreased from 5.13 Cr. (Sep 2024) to ₹3.82 Cr., marking a decrease of 1.31 Cr..
For OPM %, as of Dec 2024, the value is 6.17%. The value appears to be declining and may need further review. It has decreased from 9.09% (Sep 2024) to 6.17%, marking a decrease of 2.92%.
For Other Income, as of Dec 2024, the value is ₹0.83 Cr.. The value appears strong and on an upward trend. It has increased from 0.71 Cr. (Sep 2024) to ₹0.83 Cr., marking an increase of 0.12 Cr..
For Interest, as of Dec 2024, the value is ₹1.14 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.23 Cr. (Sep 2024) to ₹1.14 Cr., marking a decrease of 0.09 Cr..
For Depreciation, as of Dec 2024, the value is ₹1.29 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.13 Cr. (Sep 2024) to ₹1.29 Cr., marking an increase of 0.16 Cr..
For Profit before tax, as of Dec 2024, the value is ₹2.22 Cr.. The value appears to be declining and may need further review. It has decreased from 3.48 Cr. (Sep 2024) to ₹2.22 Cr., marking a decrease of 1.26 Cr..
For Tax %, as of Dec 2024, the value is 24.77%. The value appears to be improving (decreasing) as expected. It has decreased from 42.53% (Sep 2024) to 24.77%, marking a decrease of 17.76%.
For Net Profit, as of Dec 2024, the value is ₹1.67 Cr.. The value appears to be declining and may need further review. It has decreased from 2.01 Cr. (Sep 2024) to ₹1.67 Cr., marking a decrease of 0.34 Cr..
For EPS in Rs, as of Dec 2024, the value is 2.09. The value appears to be declining and may need further review. It has decreased from 2.51 (Sep 2024) to 2.09, marking a decrease of 0.42.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 2:02 pm

Metric	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	49	71	71	87	141	165	191	236
Expenses	46	67	64	74	126	147	171	216
Operating Profit	2	4	7	12	15	18	20	20
OPM %	5%	6%	10%	14%	11%	11%	10%	9%
Other Income	2	1	1	1	2	3	3	3
Interest	2	2	3	2	2	2	4	4
Depreciation	1	1	1	1	1	3	4	4
Profit before tax	1	2	3	10	15	17	14	14
Tax %	45%	26%	24%	29%	29%	30%	23%
Net Profit	1	1	3	7	10	12	11	11
EPS in Rs	0.70	1.40	3.21	9.14	13.10	14.72	13.38	13.92
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	0.00%	200.00%	133.33%	42.86%	20.00%	-8.33%
Change in YoY Net Profit Growth (%)	0.00%	200.00%	-66.67%	-90.48%	-22.86%	-28.33%

ARCL Organics Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 6 years from 2018-2019 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	%
5 Years:	22%
3 Years:	30%
TTM:	31%

Compounded Profit Growth
10 Years:	%
5 Years:	57%
3 Years:	14%
TTM:	45%

Stock Price CAGR
10 Years:	%
5 Years:	%
3 Years:	%
1 Year:	352%

Return on Equity
10 Years:	%
5 Years:	22%
3 Years:	23%
Last Year:	18%

Last Updated: Unknown

Balance Sheet

Last Updated: December 14, 2024, 2:15 pm

Month	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	8	8	8	8	8	8	8	8
Reserves	13	14	16	24	34	46	56	61
Borrowings	10	20	17	10	16	20	29	32
Other Liabilities	18	15	13	26	35	39	55	53
Total Liabilities	49	57	55	67	93	113	148	154
Fixed Assets	18	21	20	20	26	45	62	64
CWIP	0	0	0	0	0	0	0	0
Investments	0	1	1	1	1	1	1	1
Other Assets	30	35	33	47	66	66	85	89
Total Assets	49	57	55	67	93	113	148	154

Below is a detailed analysis of the balance sheet data for ARCL Organics Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is ₹8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 8.00 Cr..
For Reserves, as of Sep 2024, the value is ₹61.00 Cr.. The value appears strong and on an upward trend. It has increased from 56.00 Cr. (Mar 2024) to ₹61.00 Cr., marking an increase of 5.00 Cr..
For Borrowings, as of Sep 2024, the value is ₹32.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 29.00 Cr. (Mar 2024) to ₹32.00 Cr., marking an increase of 3.00 Cr..
For Other Liabilities, as of Sep 2024, the value is ₹53.00 Cr.. The value appears to be improving (decreasing). It has decreased from 55.00 Cr. (Mar 2024) to ₹53.00 Cr., marking a decrease of 2.00 Cr..
For Total Liabilities, as of Sep 2024, the value is ₹154.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 148.00 Cr. (Mar 2024) to ₹154.00 Cr., marking an increase of 6.00 Cr..
For Fixed Assets, as of Sep 2024, the value is ₹64.00 Cr.. The value appears strong and on an upward trend. It has increased from 62.00 Cr. (Mar 2024) to ₹64.00 Cr., marking an increase of 2.00 Cr..
For CWIP, as of Sep 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
For Investments, as of Sep 2024, the value is ₹1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 1.00 Cr..
For Other Assets, as of Sep 2024, the value is ₹89.00 Cr.. The value appears strong and on an upward trend. It has increased from 85.00 Cr. (Mar 2024) to ₹89.00 Cr., marking an increase of 4.00 Cr..
For Total Assets, as of Sep 2024, the value is ₹154.00 Cr.. The value appears strong and on an upward trend. It has increased from 148.00 Cr. (Mar 2024) to ₹154.00 Cr., marking an increase of 6.00 Cr..

Notably, the Reserves (₹61.00 Cr.) exceed the Borrowings (32.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	6	5	0	21	17
Cash from Investing Activity +	-0	-1	-7	-22	-20
Cash from Financing Activity +	-5	-4	6	3	6
Net Cash Flow	0	0	-1	1	2

Free Cash Flow

Month	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-8.00	-16.00	-10.00	2.00	-1.00	-2.00	-9.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	97	87	87	96	82	71	65
Inventory Days	59	35	45	40	43	38	58
Days Payable	102	51	43	89	88	83	110
Cash Conversion Cycle	55	71	89	48	37	25	13
Working Capital Days	56	84	89	80	75	53	47
ROCE %		9%	15%	30%	33%	28%	21%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Promoters	69.22%	69.22%	69.22%	69.22%	69.22%
DIIs	0.75%	0.75%	0.75%	0.75%	0.75%
Public	30.03%	30.04%	30.03%	30.03%	30.03%
No. of Shareholders	6,663	6,675	6,668	6,659	6,653

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	14.12	14.59	13.16	10.04	3.16
Diluted EPS (Rs.)	14.12	14.59	13.16	10.04	3.16
Cash EPS (Rs.)	19.49	17.93	14.95	11.90	4.94
Book Value[Excl.RevalReserv]/Share (Rs.)	81.88	67.81	53.18	40.21	30.43
Book Value[Incl.RevalReserv]/Share (Rs.)	81.88	67.81	53.18	40.21	30.43
Revenue From Operations / Share (Rs.)	238.40	206.32	176.58	108.34	88.48
PBDIT / Share (Rs.)	27.52	26.63	22.04	18.27	9.74
PBIT / Share (Rs.)	22.15	23.30	20.25	16.42	7.96
PBT / Share (Rs.)	18.31	20.87	18.56	14.03	4.16
Net Profit / Share (Rs.)	14.13	14.59	13.16	10.04	3.15
NP After MI And SOA / Share (Rs.)	14.13	14.59	13.16	10.04	3.15
PBDIT Margin (%)	11.54	12.90	12.48	16.86	11.00
PBIT Margin (%)	9.29	11.29	11.46	15.15	8.99
PBT Margin (%)	7.68	10.11	10.50	12.95	4.70
Net Profit Margin (%)	5.92	7.07	7.45	9.27	3.56
NP After MI And SOA Margin (%)	5.92	7.07	7.45	9.27	3.56
Return on Networth / Equity (%)	17.25	21.51	24.75	24.97	10.36
Return on Capital Employeed (%)	19.94	26.46	31.05	32.01	18.06
Return On Assets (%)	7.18	9.70	11.13	12.83	4.62
Long Term Debt / Equity (X)	0.27	0.19	0.08	0.06	0.23
Total Debt / Equity (X)	0.44	0.37	0.33	0.26	0.47
Asset Turnover Ratio (%)	1.37	1.54	0.00	1.48	0.00
Current Ratio (X)	1.37	1.47	1.59	1.94	1.70
Quick Ratio (X)	1.04	1.22	1.30	1.65	1.40
Inventory Turnover Ratio (X)	7.98	9.77	0.00	9.59	0.00
Interest Coverage Ratio (X)	7.17	10.99	13.03	7.66	2.57
Interest Coverage Ratio (Post Tax) (X)	4.68	7.02	8.78	5.21	1.83
Enterprise Value (Cr.)	48.46	0.00	0.00	0.00	0.00
EV / Net Operating Revenue (X)	0.25	0.00	0.00	0.00	0.00
EV / EBITDA (X)	2.20	0.00	0.00	0.00	0.00
MarketCap / Net Operating Revenue (X)	0.18	0.00	0.00	0.00	0.00
Price / BV (X)	0.52	0.00	0.00	0.00	0.00
Price / Net Operating Revenue (X)	0.18	0.00	0.00	0.00	0.00
EarningsYield	0.32	0.00	0.00	0.00	0.00

After reviewing the key financial ratios for ARCL Organics Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is 14.12. This value is within the healthy range. It has decreased from 14.59 (Mar 23) to 14.12, marking a decrease of 0.47.
For Diluted EPS (Rs.), as of Mar 24, the value is 14.12. This value is within the healthy range. It has decreased from 14.59 (Mar 23) to 14.12, marking a decrease of 0.47.
For Cash EPS (Rs.), as of Mar 24, the value is 19.49. This value is within the healthy range. It has increased from 17.93 (Mar 23) to 19.49, marking an increase of 1.56.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 81.88. It has increased from 67.81 (Mar 23) to 81.88, marking an increase of 14.07.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 81.88. It has increased from 67.81 (Mar 23) to 81.88, marking an increase of 14.07.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 238.40. It has increased from 206.32 (Mar 23) to 238.40, marking an increase of 32.08.
For PBDIT / Share (Rs.), as of Mar 24, the value is 27.52. This value is within the healthy range. It has increased from 26.63 (Mar 23) to 27.52, marking an increase of 0.89.
For PBIT / Share (Rs.), as of Mar 24, the value is 22.15. This value is within the healthy range. It has decreased from 23.30 (Mar 23) to 22.15, marking a decrease of 1.15.
For PBT / Share (Rs.), as of Mar 24, the value is 18.31. This value is within the healthy range. It has decreased from 20.87 (Mar 23) to 18.31, marking a decrease of 2.56.
For Net Profit / Share (Rs.), as of Mar 24, the value is 14.13. This value is within the healthy range. It has decreased from 14.59 (Mar 23) to 14.13, marking a decrease of 0.46.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 14.13. This value is within the healthy range. It has decreased from 14.59 (Mar 23) to 14.13, marking a decrease of 0.46.
For PBDIT Margin (%), as of Mar 24, the value is 11.54. This value is within the healthy range. It has decreased from 12.90 (Mar 23) to 11.54, marking a decrease of 1.36.
For PBIT Margin (%), as of Mar 24, the value is 9.29. This value is below the healthy minimum of 10. It has decreased from 11.29 (Mar 23) to 9.29, marking a decrease of 2.00.
For PBT Margin (%), as of Mar 24, the value is 7.68. This value is below the healthy minimum of 10. It has decreased from 10.11 (Mar 23) to 7.68, marking a decrease of 2.43.
For Net Profit Margin (%), as of Mar 24, the value is 5.92. This value is within the healthy range. It has decreased from 7.07 (Mar 23) to 5.92, marking a decrease of 1.15.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 5.92. This value is below the healthy minimum of 8. It has decreased from 7.07 (Mar 23) to 5.92, marking a decrease of 1.15.
For Return on Networth / Equity (%), as of Mar 24, the value is 17.25. This value is within the healthy range. It has decreased from 21.51 (Mar 23) to 17.25, marking a decrease of 4.26.
For Return on Capital Employeed (%), as of Mar 24, the value is 19.94. This value is within the healthy range. It has decreased from 26.46 (Mar 23) to 19.94, marking a decrease of 6.52.
For Return On Assets (%), as of Mar 24, the value is 7.18. This value is within the healthy range. It has decreased from 9.70 (Mar 23) to 7.18, marking a decrease of 2.52.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.27. This value is within the healthy range. It has increased from 0.19 (Mar 23) to 0.27, marking an increase of 0.08.
For Total Debt / Equity (X), as of Mar 24, the value is 0.44. This value is within the healthy range. It has increased from 0.37 (Mar 23) to 0.44, marking an increase of 0.07.
For Asset Turnover Ratio (%), as of Mar 24, the value is 1.37. It has decreased from 1.54 (Mar 23) to 1.37, marking a decrease of 0.17.
For Current Ratio (X), as of Mar 24, the value is 1.37. This value is below the healthy minimum of 1.5. It has decreased from 1.47 (Mar 23) to 1.37, marking a decrease of 0.10.
For Quick Ratio (X), as of Mar 24, the value is 1.04. This value is within the healthy range. It has decreased from 1.22 (Mar 23) to 1.04, marking a decrease of 0.18.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 7.98. This value is within the healthy range. It has decreased from 9.77 (Mar 23) to 7.98, marking a decrease of 1.79.
For Interest Coverage Ratio (X), as of Mar 24, the value is 7.17. This value is within the healthy range. It has decreased from 10.99 (Mar 23) to 7.17, marking a decrease of 3.82.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 4.68. This value is within the healthy range. It has decreased from 7.02 (Mar 23) to 4.68, marking a decrease of 2.34.
For Enterprise Value (Cr.), as of Mar 24, the value is 48.46. It has increased from 0.00 (Mar 23) to 48.46, marking an increase of 48.46.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.25. This value is below the healthy minimum of 1. It has increased from 0.00 (Mar 23) to 0.25, marking an increase of 0.25.
For EV / EBITDA (X), as of Mar 24, the value is 2.20. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 23) to 2.20, marking an increase of 2.20.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.18. This value is below the healthy minimum of 1. It has increased from 0.00 (Mar 23) to 0.18, marking an increase of 0.18.
For Price / BV (X), as of Mar 24, the value is 0.52. This value is below the healthy minimum of 1. It has increased from 0.00 (Mar 23) to 0.52, marking an increase of 0.52.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.18. This value is below the healthy minimum of 1. It has increased from 0.00 (Mar 23) to 0.18, marking an increase of 0.18.
For EarningsYield, as of Mar 24, the value is 0.32. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 23) to 0.32, marking an increase of 0.32.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of ARCL Organics Ltd as of April 3, 2025 is: 202.03

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of April 3, 2025, ARCL Organics Ltd is Overvalued by 8.17% compared to the current share price 220.00

Intrinsic Value of ARCL Organics Ltd as of April 3, 2025 is: 219.76

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of April 3, 2025, ARCL Organics Ltd is Overvalued by 0.11% compared to the current share price 220.00

Last 5 Year EPS CAGR: 8.78%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 19.43%, which is a positive sign. The company has higher reserves (33.00 cr) compared to borrowings (19.25 cr), indicating strong financial stability. The company has shown consistent growth in sales (126.38 cr) and profit (9.50 cr) over the years.	The stock has a high average Working Capital Days of 69.14, which may not be favorable. The stock has a high average Cash Conversion Cycle of 48.29, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in ARCL Organics Ltd:
1. Net Profit Margin: 5.92%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 19.94% (Industry Average ROCE: 21.5%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 17.25% (Industry Average ROE: 18.2%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 4.68
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 1.04
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 15.8 (Industry average Stock P/E: 15.8)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.44
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

ARCL Organics Ltd. is a Public Limited Listed company incorporated on 08/09/1992 and has its registered office in the State of West Bengal, India. Company's Corporate Identification Number(CIN) is L24121WB1992PLC056562 and registration number is 056562. Currently Company is involved in the business activities of Manufacture of basic chemicals. Company's Total Operating Revenue is Rs. 190.72 Cr. and Equity Capital is Rs. 8.00 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
Chemicals - Organic - Others	Rampur, P.S. Maheshtala, Budge Budge Trunk Road, Kolkata West Bengal 700141	legal@arcl.in http://www.arclorganics.com

Management
Name	Position Held
Mr. Suraj Ratan Mundhra	Chairman & Managing Director
Mr. Rajesh Mundhra	Executive Director
Mr. Brij Mohan Mohta	Ind. Non-Executive Director
Mrs. Stuti Pithisaria	Ind. Non-Executive Director
Mr. Prateek Chaudhary	Ind. Non-Executive Director

FAQ

What is the intrinsic value of ARCL Organics Ltd?

ARCL Organics Ltd's intrinsic value (as of 02 April 2025) is ₹202.03 — 8.17% lower the current market price of ₹220.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 176 Cr. market cap, FY2025-2026 high/low of ₹325/48.7, reserves of 61 Cr, and liabilities of 154 Cr.

What is the Market Cap of ARCL Organics Ltd?

The Market Cap of ARCL Organics Ltd is 176 Cr..

What is the current Stock Price of ARCL Organics Ltd as on 02 April 2025?

The current stock price of ARCL Organics Ltd as on 02 April 2025 is 220.

What is the High / Low of ARCL Organics Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of ARCL Organics Ltd stocks is ₹325/48.7.

What is the Stock P/E of ARCL Organics Ltd?

The Stock P/E of ARCL Organics Ltd is 15.8.

What is the Book Value of ARCL Organics Ltd?

The Book Value of ARCL Organics Ltd is 86.1.

What is the Dividend Yield of ARCL Organics Ltd?

The Dividend Yield of ARCL Organics Ltd is 0.00 %.

What is the ROCE of ARCL Organics Ltd?

The ROCE of ARCL Organics Ltd is 21.5 %.

What is the ROE of ARCL Organics Ltd?

The ROE of ARCL Organics Ltd is 18.2 %.

What is the Face Value of ARCL Organics Ltd?

The Face Value of ARCL Organics Ltd is 10.0.